New to injecting Botox®? This guide walks you through the most common mistakes—and how to avoid them—so you can deliver safe, natural-looking results your patients will love.

Letybo® received FDA approval on February 29, 2024, for the temporary improvement of moderate to severe glabellar lines in adult patients. With its high purity, precise diffusion pattern, and impressive clinical results, Letybo® offers medical providers a valuable new option in aesthetic medicine.

With funding cuts, shrinking reimbursements, and rising burnout rates, many physicians are looking for a more stable, flexible income stream. Aesthetic medicine offers a cash-based, high-profit alternative without the stress of insurance billing or long hospital shifts. In just a few days of training, providers can start offering in-demand, non-invasive treatments and take back control of their lives.